JNJ — Johnson & Johnson Income Statement
0.000.00%
Last trade - 00:00
- $398.45bn
- $414.46bn
- $85.16bn
- 100
- 43
- 83
- 88
2019 December 29th | 2021 January 3rd | R2022 January 2nd | 2023 December 31st | R2023 January 1st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 82,059 | 82,584 | 78,740 | 85,159 | 79,990 |
Cost of Revenue | |||||
Gross Profit | 54,603 | 54,257 | 55,338 | 58,915 | 55,394 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 64,731 | 66,087 | 59,562 | 70,097 | 60,631 |
Operating Profit | 17,328 | 16,497 | 19,178 | 15,062 | 19,359 |
Net Income Before Taxes | 17,328 | 16,497 | 19,178 | 15,062 | 19,359 |
Provision for Income Taxes | |||||
Net Income After Taxes | 15,119 | 14,414 | 17,801 | 13,326 | 16,370 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 15,119 | 14,714 | 20,878 | 35,153 | 17,941 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 15,119 | 14,714 | 20,878 | 35,153 | 17,941 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.22 | 6.99 | 7.14 | 8.33 | 7.29 |
Dividends per Share |